ALVO News

FDA approves additional U.S. manufacturing capacity for SIMLANDI®, Alvotech’s biosimilar to Humira®

FDA approves additional U.S. manufacturing capacity for SIMLANDI®, Alvotech’s biosimilar to Humira®

Alveo Technologies and Royal GD Expand Partnership to Advance Point of Need Molecular Diagnostics to Additional Livestock Species & Expanded Poultry Offerings

Alvotech Announces FDA Acceptance for Review of Biologics License Application for AVT80, Expanding Proposed Biosimilar Program for Entyvio® to Subcutaneous Presentations

Alvotech announces FDA acceptance for review of Biologics License Application for AVT80, expanding proposed biosimilar program for Entyvio® to subcutaneous presentations

Alvotech to present at upcoming investor conferences in September

Alvotech to present at upcoming investor conferences in September

Alveo Technologies Partners with AgriNerds to Create First-of-its-Kind, Dynamic Avian Influenza Surveillance System for U.S. Poultry Farmers

Alvotech Announces Licensing and Commercialization Agreement with Lotus Pharmaceutical for proposed biosimilars to durvalumab and emicizumab in the U.S. and Selected Asian Markets

Alvotech Announces Licensing and Commercialization Agreement with Lotus Pharmaceutical for proposed biosimilars to durvalumab and emicizumab in the U.S. and Selected Asian Markets